Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Safety of continuing chemotherapy in overt left...
Conference

Safety of continuing chemotherapy in overt left ventricular dysfunction using antibodies to human epidermal growth factor receptor-2: A retrospective study

Authors

Bharaj UK; Leong D; Dhesy-Thind S; Ellis P; Mukherjee S; Bordeleau L; Phillips C; Brown M; Tyagi NK

Volume

78

Publisher

AMER ASSOC CANCER RESEARCH

Publication Date

February 1, 2018

Name of conference

San Antonio Breast Cancer Symposium

Conference place

San Antonio, TX

Conference start date

December 5, 2017

Conference end date

December 9, 2017

Conference proceedings

CANCER RESEARCH

Issue

4

ISSN

0008-5472